Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Wilms Tumor 1Unspecified Childhood Solid Tumor, Protocol Specific 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Osteosarcoma 1Neuroectodermal Tumors 1Neuroblastoma 1Mesothelioma, Malignant 1Hepatoblastoma 1Adrenocortical Carcinoma 1

Interventions

Granulocyte Colony-Stimulating Factor 5Thiotepa 3Melphalan 3Busulfan 3Mesna 2Ifosfamide 2Filgrastim 2Etoposide 2sargramostim 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1etoposide phosphate 1cixutumumab 1Ursodeoxycholic Acid 1Topotecan 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Radiotherapy, Intensity-Modulated 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Nivolumab 1Leukapheresis 1Granulocyte-Macrophage Colony-Stimulating Factor 1Cyclophosphamide 1Carboplatin 1Bone Marrow Transplantation 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatoblastoma × cixutumumab × Other solid neoplasm × Clear all
NCT00831844 2015-03-30

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 2 Completed
116 enrolled 8 charts
CNSEndocrineGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Wilms Tumor, Neuroblastoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Neuroectodermal Tumors, Hepatoblastoma, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡